1. 102. Address the dosimetry in radiometabolic therapy; relationship between dosimetric value and clinical parameters in differentiated thyroid cancer. (December 2018) Authors: Rossi, G.; Scaccia, L.; Busonero, G.; Capoccetti, F.; Camarda, M.; Bartolozzi, C.; D'Avenia, P; Dente, AM; Di Nicola, E.; Gasparrini, N.; Fattori, S Journal: Physica medica Issue: Volume 56(2018)Supplement 2 Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Overall survival in intermediate-stage hepatocellular carcinoma (HCC) patients after first transarterial chemoembolization (TACE): proposal of a new scoring system. (15th February 2015) Authors: Sacco, R.; Ginanni, B.; Mismas, V.; Masi, G.; De Simone, P.; Romano, A.; Bresci, G.; Bartolozzi, C.; Bargellini, I. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Red marrow dosimetry in differentiated thyroid cancer (DTC): Comparison between previsional and post therapy dose for multitreated patients and follow-up. Issue 1 (February 2016) Authors: Rossi, G.; Camarda, M.; D'Avenia, P.; Di Nicola, E.; Montani, L.; Bartolozzi, C.; Dente, A.M.; De Angelis, F.; Gasparrini, N.; Brianzoni, E.; Fattori, S. Journal: Physica medica Issue: Volume 32:Issue 1(2016)supplement 1 Page Start: 112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗